Clearside Biomedical
$0.41
31
-$0.15-26.92% Friday 22:45
Statistics
Day High
0.41
Day Low
0.41
52W High
17.1
52W Low
0.31
Volume
2,046,591
Avg. Volume
261,596
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
5MarExpected
Expected EPS
-0.6
Actual EPS
N/A
Financials
-2,064.42%Profit Margin
Unprofitable1.66MRevenue
-34.35MNet Income
Analyst Ratings
$0.00Average Price Target
The highest estimate is 0.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 0%
Hold 100%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CLSD. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
EyePoint
EYPT
Mkt Cap1.06B
Bausch Health Companies
BHC
Mkt Cap2.62B
Novartis
NVS
Mkt Cap237.61B
Regenxbio
RGNX
Mkt Cap645.07M
Ocular Therapeutix
OCUL
Mkt Cap2.47B
GSK
GSK
Mkt Cap94.51B
About
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.
Show more...
CEO
Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
Employees
32
Country
US
ISIN
US1850632035
Listings
0 Comments
Share your thoughts
FAQ
What is Clearside Biomedical stock price today?▼
The current price of CLSD is $0.41 USD — it has decreased by -26.92% in the past 24 hours. Watch Clearside Biomedical stock price performance more closely on the chart.
What is Clearside Biomedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Clearside Biomedical stocks are traded under the ticker CLSD.
Is Clearside Biomedical stock price growing?▼
CLSD stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Clearside Biomedical has showed a -97.06% decrease.
What is Clearside Biomedical revenue for the last year?▼
Clearside Biomedical revenue for the last year amounts to 1.66M USD.
What is Clearside Biomedical net income for the last year?▼
CLSD net income for the last year is -34.35M USD.
How many employees does Clearside Biomedical have?▼
As of April 02, 2026, the company has 32 employees.
In which sector is Clearside Biomedical located?▼
Clearside Biomedical operates in the Health Care sector.
When did Clearside Biomedical complete a stock split?▼
The last stock split for Clearside Biomedical was on September 15, 2025 with a ratio of 1:15.
Where is Clearside Biomedical headquartered?▼
Clearside Biomedical is headquartered in Alpharetta, US.